SEARCH

SEARCH BY CITATION

Keywords:

  • antigen presentation;
  • autophagy;
  • cross-presentation;
  • endoplasmic reticulum;
  • endosome;
  • major histocompatibility complex;
  • phagocytosis;
  • phagosome;
  • retrotranslocation;
  • toll-like receptors

Abstract

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

Phagocytosis provides innate immune cells with a mechanism to take up and destroy pathogenic bacteria, apoptotic cells and other large particles. In some cases, however, peptide antigens from these particles are preserved for presentation in association with major histocompatibility complex (MHC) class I or class II molecules in order to stimulate antigen-specific T cells. Processing and presentation of antigens from phagosomes presents a number of distinct challenges relative to antigens internalized by other means; while bacterial antigens were among the first discovered to be presented to T cells, analyses of the cellular mechanisms by which peptides from phagocytosed antigens assemble with MHC molecules and by which these complexes are then expressed at the plasma membrane have lagged behind those of conventional model soluble antigens. In this review, we cover recent advances in our understanding of these processes, including the unique cross-presentation of phagocytosed antigens by MHC class I molecules, and in their control by signaling modalities in phagocytic cells.

image

Antigen presenting cells (APCs) are critical regulators of immunity that continuously survey their microenvironment, take up antigenic materials, process them and present the resulting fragments to antigen-specific T lymphocytes in the context of molecules of the major histocompatibility complex (MHC) or related proteins. APCs capture exogenous matter through different mechanisms, including receptor-mediated endocytosis, pinocytosis and phagocytosis. Phagocytosis is defined as the engulfment of large particulate antigens, such as bacterial pathogens, in a process requiring actin remodeling to form a cup around the particle that eventually closes to form a phagosome (reviewed in [1] [2]). Once formed, phagosomes mature through extensive interactions with the endocytic system into phagolysosomes, such that the enclosed particles become exposed to an increasingly harsh lumenal environment (reviewed in [1] [3], [4]). Although phagosome maturation in many ways resembles endosome maturation [4], phagosomes have properties that are distinct from those of conventional endosomes and that differ among phagocytic cell types [5]. Moreover, phagosome maturation programs can be altered in response to innate signaling pathways initiated by the enclosed particles or by effectors generated by pathogenic bacteria [1, 3, 6]. Thus, the fate of cargoes that are ingested by phagocytosis or non-phagocytic mechanisms can differ among cell types and even within the same cell type.

Initially described in invertebrates by Elie Metchnikov in 1908 [7], phagocytosis was for many years conceived as an innate immunity mechanism that served only to destroy an exogenous agent. With the study of adaptive immunity, the discovery of dendritic cells (DCs) as key APCs at the interface of innate and adaptive immune responses [8], and the description of pattern recognition receptors in APCs that can discriminate between self and non-self, [9], increased evidence shows a tight interplay between innate and adaptive immunity pathways that places the phagosome at the crossroads of different routes, one of them leading to antigen presentation. Recent studies have provided substantial insights into mechanisms of phagosome maturation, the regulation of phagosome maturation by signals from pattern recognition receptors, and the requirement for particular phagosome functions in antigen processing in ‘professional phagocytes’ (DCs, macrophages and neutrophils) and other cell types that can undergo phagocytosis under inflammatory conditions.

Here we review the cell biological aspects of antigen presentation through the eyes of phagocytes. We focus on two distinct antigen processing pathways for presentation by MHC class I (MHC-I) and MHC class II (MHC-II) molecules. Phagocytosis plays a traditional role in providing ligands for MHC-II, but recent studies suggest that phagosomes might alter the conventional pathway for MHC-II antigen processing in as yet undefined ways. MHC-I molecules are normally loaded with peptides derived from cytosolic proteolysis, but phagosomes in a sub-class of DCs are specialized for cross-presentation, an unusual process by which protein antigens on endocytosed or phagocytosed particles provide ligands for MHC-I. The mechanisms by which phagocytosed antigens access the cytosol are still unclear, but recent insights have elucidated some of the key molecular players and compartments in this process.

Throughout this review, we refer to published experiments that use different models of particulate antigens internalized by phagocytosis. These include several classes of pathogenic and non-pathogenic bacteria, live or heat killed bacteria or inert beads conjugated to model antigens and/or ligands for innate immune receptors. In some cases, the consequences of exposure to different particulate antigen models have been compared to each other and to those of soluble ligands that are internalized by other mechanisms, whereas in other cases only single models have been analyzed. It is important for readers to appreciate that both the type of particulate antigen and the mode of internalization can strongly influence the results and the models derived from them. We hope that this review makes these differences sufficiently clear and encourage others to investigate the molecular basis for them.

Processing and Presentation of Phagocytosed Antigens by MHC-I and -II

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

The MHC-I processing pathway is largely geared toward presentation of endogenous antigens encountered in the cytoplasm, nucleus and mitochondria of most cell types. Peptides derived by cytosolic proteolysis of such antigens are translocated into the endoplasmic reticulum (ER), where they encounter and may assemble with newly synthesized MHC-I molecules (see below). Cross-presentation by MHC-I is a distinctive process in which antigens from phagocytosed particles or soluble proteins internalized by other means are assembled with MHC-I. This process is largely restricted to specific DC subsets in vivo [10, 11], but can be replicated in other model cell types in culture. By contrast, MHC-II molecules – which are limited in expression to ‘professional’ APCs (DCs, macrophages, B lymphocytes) and to a few limited other cell types after appropriate stimulation – are specialized to present antigens internalized from the extracellular space [12]. Historically, phagosomes were well recognized to provide antigens for presentation by MHC-II molecules on phagocytic cells such as macrophages and DCs before they were considered important sources of cross-presented antigen [13-16]. Burgdorf and Kurts [17] proposed that processing of phagocytosed antigens for cross-presentation by MHC-I and for presentation by MHC-II occurs sequentially, such that the mild environment of early phagosomes would favor MHC-I-dependent cross-presentation [18] and processing for MHC-II presentation would take place on late phagosomes characterized by a decreased pH and increased proteolytic activity. Before discussing the role and regulation of phagosomes in antigen processing, we briefly summarize the general pathways of MHC-I and -II antigen presentation.

Molecular and cell biology of antigen presentation by MHC-II

MHC-II molecules are composed of two integral membrane chains, α and β, both encoded within the MHC. The peptide-binding pocket is comprised of the membrane distal domains of both chains. Association of nascent α and β chains with invariant chain (also called Ii or CD74) in the ER facilitates MHC-II assembly and ER exit, occludes the peptide binding site and prevents premature binding of peptides [19]. Ii also facilitates transport of MHC-II complexes to the endosomal system; most evidence supports transport via the cell surface [20, 21], but alternative Ii isoforms might facilitate direct transport from the Golgi to endosomes [22]. Within late endosomal compartments – which in professional APCs are often referred to as MIIC for MHC-II-containing compartments [23] – Ii is degraded by resident proteases leaving only the peptide binding region, CLIP, bound to MHC-II [24]. Simultaneously, internalized proteins are also degraded by resident proteases, generating potential antigenic and non-antigenic peptide MHC-II ligands. The MIIC-resident protein HLA-DM then facilitates peptide exchange to promote CLIP dissociation and subsequent peptide binding to the MHC-II binding pocket [25, 26]. MHC-II:peptide complexes are then delivered to the cell surface by mechanisms that are still poorly understood [27-29], where they are available to stimulate antigen-specific CD4+ T cells with cognate receptors.

Peptide loading onto MHC-II molecules can occur in multiple compartments of the endocytic pathway. Most newly synthesized MHC-II molecules are likely loaded in late endosomal MIICs in an HLA-DM-dependent mechanism, whereas internalized MHC-II αβ dimers from the cell surface can be ‘reloaded’ with peptides within the early endosomal system [30]. Late endosomal MIIC are likely to be the primary site for antigen loading for the bulk of MHC-II in B lymphocytes or DCs, because they harbor at steady state all known factors required for efficient peptide loading (acidic pH, presence of cathepsins, HLA-DM activity) [31], as recently described for a minimal in vitro reconstitution system [32]. By electron microscopy analyses in B lymphocytes and DCs, MIIC have both multivesicular and multilamellar morphologies [23, 33-35]. The current consensus suggests that these morphologies represent the extremes of different maturation states [36, 37]. Caution must be taken in inferring the sites of MHC-II: peptide complex formation based on their sites of accumulation, as recent work suggests that the pool of MHC-II in multivesicular endosomes in immature DCs does not contribute to the pool of antigen-presenting MHC-II upon DC maturation [38].

Molecular and cell biology of antigen presentation by MHC-I

MHC-I molecules are composed of two chains – the polymorphic, MHC-encoded α chain and the relatively non-polymorphic β2 microglobulin (β2m) light chain – that assemble in the ER [39]. This assembly, however, is only complete if a peptide binds in the groove of the MHC-I molecule. A sophisticated ‘quality control’ mechanism that is based on the status of the N-linked oligosaccharides on the α chain prevents the export of incompletely assembled α chain/β2m/peptide trimers from the ER (a similar mechanism operates to ensure that only complete nonameric MHC-II αβIi complexes efficiently exit the ER). The peptides that bind MHC-I molecules are usually eight to nine amino acids long. Precursors of these peptides are generated in the cytosol mainly from incomplete translation products (DRIPs) that are partially degraded by the proteasome, but can also include other misfolded proteins or retrotranslocated proteins from the ER cleaved by the proteasome or other cytosolic proteases [40]. The peptides are then translocated into the lumen of the ER by dedicated ATP-dependent TAP1/2 transporters and trimmed at their N-termini by ER proteases called ERAAPs. Transfer of the trimmed peptides from TAP onto folding MHC-I is promoted by a ‘loading complex’, composed of a dedicated chaperone, Tapasin and a series of general membrane bound and soluble chaperones (including calnexin, ERP57 and calreticulin) [39]. Once assembled, the MHC-I/β2m/peptide complexes are exported from the ER via the classical secretory pathway and are expressed at the plasma membrane. The loading of MHC-I molecules by endogenously produced peptides plays a critical role in the killing of virally infected cells, tumor cells and transplanted allogeneic cells by effector CD8+ cytotoxic T lymphocytes (CTL).

Cross-presentation by MHC-I

The endogenous pathway just described is responsible for loading all or most peptides onto MHC-I molecules in most cells in the body. During the initiation of immune responses, however, the situation turns out to be more complex. It has become clear over the last 20 years that DCs initiate most immune responses [41]. Although, some viruses can infect DCs and generate MHC-I peptide ligands by the classical pathway, in many cases – such as for responses to bacteria, parasites, tumors, allogeneic transplants and viruses that do not infect DCs – the antigens are not expressed by the DCs themselves. In many of these cases, it has been shown that DCs can phagocytose antigens from microbes or from infected or allogeneic cells, and cross-present peptides derived from these antigens on their own MHC-I. How, then, are these antigens processed for loading on MHC-I for cross-presentation?

Two main intracellular models for cross-presentation have been proposed, and are generally referred to as the ‘vacuolar’ and ‘cytosolic’ pathways [42] (Figure 1). The vacuolar pathway model proposes that internalized antigens are processed into peptides that can bind MHC-I directly in endosomes and phagosomes. The MHC-I molecules in this model likely access endocytic compartments by recycling from the plasma membrane, and would bind peptides independently of proteasomal degradation, TAP transporters or the MHC-I loading complex. The cytosolic pathway model proposes that antigens, most likely after partial degradation [43], are exported to the cytosol and processed by the proteasome as for endogenous MHC-I processing. These exogenous proteasome-processed peptides could then be loaded onto MHC-I molecules in the ER following TAP-dependent uptake. Alternatively, ER-resident proteins including TAP and the MHC-I loading machinery can be recruited to phagosomes and perhaps even to endosomes [17]; thus, peptides generated by the proteasome might be translocated back into the lumen of endocytic compartments for loading on MHC-I molecules, which could then recycle back to the plasma membrane [44]. In either case, by exploiting the proteasome and TAP, the cytosolic pathway would provide a means by which DCs can present the same peptides from internalized antigens that are generated endogenously in other cell types, and thus stimulate relevant CD8+ T cells.

image

Figure 1. Models of phagosomal antigen cross-presentation by MHC-I. Shown are the two main proposed models for intracellular pathways leading to cross-presentation of exogenous antigens in DCs. Left, the TAP- and proteasome-dependent cytosolic pathway. In this scenario, antigens on phagocytosed particles are exported to the cytosol by an ERAD-associated retrotranslocon, ubiquitylated and targeted to the proteasome for degradation. The generated peptides are then either translocated back into the phagosome by TAP and loaded onto MHC-I (1) or fed into the classical TAP-dependent MHC-I antigen presentation pathway in the ER (2). ERGIC-derived membranes that fuse with phagosomes are the likely source of the phagosomal retrotranslocon, TAP, and perhaps newly synthesized MHC-I. Right, the TAP- and proteasome-independent vacuolar pathway. In this scenario, peptides are generated from antigens on phagocytosed particles within phagosomes by proteolysis mediated by cathepsins. These peptides are then loaded onto itinerant MHC-I molecules within the phagosome.

Download figure to PowerPoint

In our opinion, there are to date no definitive results that prove or exclude any of these possibilities. Most of the experimental evidence supporting presentation of a particular antigen through the vacuolar or cytosolic pathways comes from interfering with either endocytic (lysosomal proteases), cytosolic (proteasomal proteolysis) or ER-related (TAP or loading complex) functions. The problem is that the three intracellular compartments are involved in all pathways. Inhibiting the proteasome or TAP deprives newly synthesized MHC-I of peptides, causing retention of incompletely folded molecules in the ER and thereby reducing the pool of available MHC-I in endocytic compartments and the plasma membrane. Inhibiting endocytic functions can prevent generation of MHC-I binding peptides in endosomes and phagosomes, but it can also interfere with the initial partial degradation steps that are required for the export of some antigens to the cytosol. Therefore, most of the arguments in favor or against the use of the vacuolar or cytosolic pathways for presentation of particular antigens are to be taken with caution. One convincing argument supporting the use of the cytosolic pathway derives from an in vivo experiment for presentation of the male antigen Uty [45]. A peptide derived from Uty that is presented to T cells can only be generated by the immunoproteasome, which is a variant of the conventional proteasome harboring three interferon-responsive subunits; male mice lacking one of these subunits, LMP-7, cannot present the Uty epitope. Whereas endogenous MHC-I presentation of other antigens is intact in these mice, cross-presentation of Uty in vivo is also impaired in LMP-7−/− mice. This experiment provides direct evidence that the Uty epitope is processed through the cytosolic pathway even during cross-presentation.

While the relative contributions of vacuolar and cytosolic pathways to cross-presentation are murky, the molecular mechanisms underlying either process are even less well-defined. In particular, the mechanisms of antigen export to the cytosol, the intracellular compartments where peptides are loaded onto MHC-I (ER versus endocytic), the origin of the MHC-I that is loaded with cross-presented peptides (recycling or newly synthesized) and their paths for transport to the surface remain to be established.

Phagosomes as Antigen Presentation Compartments

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

Given the role of endosomes as antigen processing compartments and the extensive interplay between organelles of the endocytic pathway and maturing phagosomes [4], it is not surprising that antigens from phagocytosed particles are processed and presented by MHC-I and -II.

Phagosomal presentation by MHC-II

Harding and Geuze detailed the processing of phagocytosed Listeria monocytogenes and the contents of phagosomes and phagolysosomes in macrophages [14], showing that macrophages present antigen from internalized particles by MHC-II with kinetics similar to those of bacterial destruction and of arrival of MHC-II in phagosomes. Consistent with these observations, elegant studies using subcellular fractions of macrophages that had phagocytosed antigen-bound latex beads showed that phagosomes acquired MHC-II, H-2DM and Ii within 30 min following uptake, and that MHC-II:peptide complexes formed within phagosomes and were subsequently transported to the cell surface [46]. Similar observations were made with macrophages that had taken up heat-killed Mycobacterium tuberculosis [47]. These observations suggested that phagosomes themselves can serve as MHC-II processing compartments and provide an environment conducive to the assembly of MHC-II:peptide complexes, and that such complexes are delivered directly to the cell surface from maturing phagosomes (Figure 2).

image

Figure 2. Model of phagosomal antigen processing and presentation by MHC-II. MHC-II processing and presentation from phagosomes. (1) Phagocytosed antigen captured by APCs is unfolded and degraded in phagosomes as the phagosomes mature. Maturation is achieved by the acquisition of content (including MHC-II molecules) from early and late endosomes and lysosomes by both direct fusion (open arrows) and vesicular transport (turquoise arrows; dashed arrows indicate possible pathways for MHC-II transport that are not yet confirmed). Antigen is loaded onto MHC-II molecules predominantly in late phagosomes. Phagosome maturation is supported by autophagy (ATG; violet) proteins, which might derive from autophagosomes themselves or independently from the cytosol, and by signaling from PRRs (black arrow). Some PRRs are delivered to phagosomes from early endosomes in an AP-3-dependent manner (mauve dashed arrow). (2) From late phagosomes, peptide-loaded MHC-II molecules are delivered to the cell surface either directly (not shown) or via an intermediate tubular MHC-II storage compartment that might be similar to the compartment derived from classical non-phagosomal MIIC. Delivery to or from this compartment might be regulated by PRR signaling from the phagosome (dashed black arrows) or perhaps directly by AP-3 (dashed mauve arrow).

Download figure to PowerPoint

In other cases, however, MHC-II:peptide complexes appear to accumulate in compartments other than phagosomes prior to cell surface appearance. For example, using subcellular fractionation of macrophages at various times following infection with Streptomyces pyogenes, von Delwig et al. found that fractions enriched in endosomes, but not phagosome-enriched fractions, could simulate pathogen-specific CD4+ T cells [48]. The time course over which these complexes formed depended on the specific peptide generated. Similarly, using immunofluorescence microscopy with an antibody that recognizes the I-Ab MHC-II molecule complexed with a peptide derived from I-Eα [49, 50], MHC-II:peptide complexes accumulated on non-endosomal/non-lysosomal vesicular compartments, but not on phagosomes, in DCs following uptake of latex beads conjugated to an Eα fusion protein [51]. These data indicate that MHC-II complexes with peptides derived from phagocytosed antigen can accumulate in distinct compartments following their formation, perhaps owing to variations on phagosome maturation that occur in macrophages during infection with certain bacteria or in DCs. Whether these complexes form in phagosomes and are then rapidly transported to post-phagosomal compartments, or form in separate MHC-II-containing compartments following antigen export from phagosomes is not yet clear. The visualization of MHC-II complexed with a peptide derived from Leishmania major within both the L. major-containing phagosome and in separate endocytic compartments in DCs [52] supports the assembly of such complexes in phagosomes with subsequent accumulation in plasma membrane-bound transport vesicles, but definitive proof of such a pathway will necessitate careful time lapse experiments.

Trafficking of MHC-II and regulators to MIIC and phagosomes

The molecular mechanisms that regulate trafficking of MHC-II from the secretory pathway to endosomes and conventional MIIC have received substantial attention, but are still unresolved. Targeting of MHC-II molecules to MIIC is facilitated by the associated Ii, and requires two dileucine-based sorting signals in the Ii cytoplasmic domain [53-55]. Similar signals in other endosomal proteins bind in vitro to the ‘trunk’ domain of members of the adaptor protein complexes, which are components of clathrin coats involved in vesicle formation and cargo sorting within the endosomal system [56]. Indeed, some evidence suggests that the Ii sorting signals bind AP-2 – the cell surface adaptor for clathrin-dependent endocytosis – and AP-1 – which functions in protein sorting at the TGN and endosomes [57]. In HeLa cells that express MHC-II and associated molecules (by virtue of expression of the CIITA transcription factor), depletion of clathrin or AP-2 delayed Ii degradation and reduced surface expression of peptide-loaded MHC-II molecules, whereas depletion of AP-1 or two other endosomal adaptors, AP-3 or AP-4, had little or no effect [21, 58]. Consistently, AP-3 – which functions in cargo sorting from early endosomes to late endosomes/lysosomes or lysosome-related organelles [59] – was dispensable for MHC-II biosynthetic transport and general peptide loading in human EBV-transformed B cells and mouse spleen cells [60, 61] and for presentation of antigen internalized by receptor-mediated endocytosis in DCs [51]. These findings demonstrate that clathrin and AP-2 participate in MHC-II molecule trafficking in vivo and that a significant pool of MHC-II molecules traffics to the endosomal-lysosomal system via the cell surface, but additional sorting events may be adaptor-independent. This was surprising given that MHC-I and -II molecules diverge at the TGN in EBV-transformed B lymphocytes [23]. Recent work has shown that non-muscle myosin II plays an important role in clustering MHC-II into centralized lysosomal compartments, perhaps via direct interaction with MHC-II/Ii complexes, and is required for subsequent formation of MHC-II:peptide complexes in B lymphocytes [62]. Whether this reflects a general role for myosin II in export from the Golgi [63, 64] or a specific role for post-Golgi MHC-II trafficking is not yet clear. MHC-II molecules accumulate on phagosomes during phagosome maturation in macrophages [14] and DCs [65], but how MHC-II molecules are transported to phagosomes is not understood. Phagosomal acquisition of MHC-II in macrophages and DCs coincides with the acquisition of lysosomal proteins such as cathepsins and the integral membrane proteins LAMP1 and LAMP2 [66, 67], suggesting that MHC-II is targeted to phagolysosomes and to traditional late endosomes and lysosomes by the same intracellular transport pathways. Alternatively, MHC-II/Ii complexes might be incorporated into phagosomal membranes during endosome/phagosome fusion [14, 68]. Recent work in macrophages has shown that the small GTPase, Arl8b, facilitates phagolysosome fusion (and lysosome maturation) by recruiting the HOPS complex – a tethering complex that facilitates SNARE-dependent fusion – to lysosomes [69]. Depletion of Arl8b impairs phagosome maturation and assembly of ligands with another antigen-presenting molecule, CD1b, and would be predicted to interfere with MHC-II peptide loading as well [69]. Resolution of the mechanism by which MHC-II and associated components (such as H-2DM) are delivered to phagosomes will likely require live-cell imaging with selective visualization of transport intermediates using photoactivatable probes. Interestingly, the rate of MHC-II transport to and retention within phagosomes can be regulated in DCs by the nature of the phagosomal cargo. For example, MHC-II is acquired more rapidly and retained longer in phagosomes that harbor TLR ligand-coated latex beads than those harboring M. tuberculosis [70].

Several studies have shown that mature MHC-II-peptide complexes can be modified by polyubiquitylation of the MHC-II β chain, and in some cases also the α chain [71], by the E3 ubiquitin ligase, MARCHI [72-75]. This modification leads to down-regulation of mature MHC-II molecules, and is at least in part responsible for the low level of surface MHC-II expression in immature DCs in which MARCHI expression is high [72, 74, 75]. The mechanism by which ubiquitylation down-regulates MHC-II is debated. While initial studies suggested that ubiquitylation influenced MHC-II:peptide endocytosis [73, 74], recent work implies instead that it functions during post-endocytic targeting of constitutively internalized MHC-II molecules for degradation in lysosomes, presumably by the multivesicular body pathway [76]. Intriguingly, ubiquitylation and down-regulation of MHC-II in mature DCs or macrophages is stimulated by at least two pathogenic intracellular bacteria, Francisella tularensis and Salmonella typhimurium [77, 78]. Nevertheless, how ubiquitylation contributes to MHC-II trafficking to or from phagosomes is not known.

Cell surface delivery of MHC-II:peptide complexes

Once they are formed in MIIC, phagosomes, or post-phagosomal compartments, MHC-II:peptide complexes must then be delivered to the plasma membrane in order to be available to stimulate antigen-specific CD4+ T lymphocytes. MHC-II cell surface delivery from conventional MIIC has been visualized in model APCs and LPS-stimulated bone marrow-derived DCs using GFP-tagged MHC-II [27-29, 79], and intermediates in transport have been visualized by electron microscopy [80-82], but the mechanisms underlying this process are poorly understood. MIIC in a model APC have been shown to move bidirectionally along microtubules through the activity of the motor proteins dynein and kinesin [83], and eventually fuse with the plasma membrane without intersecting endosomal compartments [27]. Similarly, MHC-II:peptide complexes In B lymphocytes are delivered from MIIC to the cell surface without intersecting early endosomes [84], and MIIC fusion profiles observed at the plasma membrane result in secretion of the intralumenal vesicles of multivesicular MIICs [80]. In DCs, MHC-II:peptide assembly and export from MIICs to the plasma membrane are stimulated by maturation through TLRs or other receptors [85, 86], and coincides with a transition of MIICs from vesicular to tubular structures  [28, 29, 81, 87], at least some of which lack lysosomal markers [82]. These tubules have been proposed to be the carriers to mediate cell surface delivery of MHC-II. They have not been observed in immature DCs, B cells or melanoma cells, suggesting that they represent a unique specialization of mature DCs [88]. Similar analyses have not been as thoroughly applied to phagosome-associated MHC-II:peptide complexes. Nevertheless, MHC-II-containing tubules emerging from L. monocytogenes-containing phagolysosomes in macrophages have been observed by electron microscopy [14], suggesting that delivery of phagosome-derived MHC-II:peptide complexes to the plasma membrane might also occur via tubular intermediates. The punctate compartments in which phagosome-derived MHC-II:peptide complexes accumulate following antigen-coated latex bead phagocytosis in formaldehyde-fixed DCs [51] might represent remnants of such tubules, as they lack lysosomal or early endosomal markers.

Small GTPases of the Rab and Arl family are among the few components known to regulate MHC-II trafficking following peptide loading. Rab proteins regulate membrane traffic through the selective membrane recruitment of cytosolic effector proteins, such as sorting adaptors, tethering factors, kinases, phosphatases and motors (reviewed in [89]). RAB7, a well-known regulator of late endosomal dynamics and early to late endosome maturation [90], is detected on late endosome and MIIC membranes [27, 91]. RAB7 is expressed at low levels in resting B lymphocytes but is up-regulated following stimulation, and RAB7 overexpression enhances MHC-II antigen presentation kinetics [92]. RAB7 recruits the dynein motor complex to MIIC [93, 94], allowing retrograde movement along microtubules and likely regulating MIIC release to the plasma membrane. In order to accumulate MIIC or other MHC-II-containing compartments in the periphery, dynein must be inactivated or released, which would likely require inactivation of RAB7 by a GTPase activating protein (GAP). Additional candidate regulators of late steps in MHC-II transport were recently identified in a multidimensional RNAi screen in a melanoma model APC [95]. Among the many exciting ‘hits’ in this screen was a pathway centered about the small GTPase, ARL14/ARF7. ARL14/ARF7 localized to MIIC in immature DCs, due in part to recruitment of the ARL14/ARF7 guanine nucleotide exchange factor (GEF), PSD4, by phosphoinositides generated by the phosphatidylinositide (PtdIns) kinases PIP5K1A and PIK3R2. GTP-bound ARL14/ARF7 in turn bound an effector protein, ARF7EP, which recruits the actin-based motor, MYO1E. In this way, ARL14/ARF7 may connect MIIC to the actin network via ARF7EP-MYO1E to control export of MHC-II. Consistently, silencing of ARL14/ARF7 in immature DCs resulted in a mature DC-like MHC-II distribution, as observed by confocal microscopy [95]. While a role for these pathways in MHC-II delivery from phagosomes has not yet been established, similar networks are likely to function. For example, PIP5K1A plays a critical role early in phagosome formation [96], and RAB7 has extensive interactions with phagosomes in macrophages and other phagocytes [97].

Endosomes, phagosomes and cross-presentation

By definition, the first steps of all cross-presentation pathways (vacuolar or cytosolic) occur in endocytic compartments. Models for cross-priming are mainly based on particulate antigen, as injected soluble proteins inefficiently induce cross-priming in vivo, and coupling a protein antigen to beads – which forces uptake by phagocytosis – strongly increases the efficiency of cross-presentation [98]. In macrophages, inducing macropinocytosis also stimulates cross-presentation [99]. These results suggest that the mode of internalization influences cross-presentation, but the mechanisms involved remain obscure.

Regardless of the mode of entry, the parameters that influence cross-presentation by DCs adhere to a set of rules. For example, to be cross-presented, internalized antigens need to be released in the endocytic lumen – either for lysosomal processing in the vacuolar pathway or for export to the cytosol in the cytosolic pathway. This requirement is easy to fulfill for soluble antigens that are internalized or secreted into phagosomes by living microbes, but to release non-secreted microbial antigens for cross-presentation the microbes must be killed and at least partially degraded. Furthermore, antigen release from large protein aggregates requires disaggregation and lysosomal proteolysis [43]. Therefore, the proteolytic activity of the endocytic pathway is required for cross-presentation of at least some antigens through both the vacuolar and cytosolic pathways. On the other hand, excessive endocytic proteolysis is detrimental to cross-presentation as shown using several approaches. First, the efficiency of cross-presentation is enhanced by interfering with endocytic acidification by treatment with weak bases such as chloroquine [100], and antagonized by increased acidification due to genetic defects that interfere with the alkalinizing activity or recruitment of the phagocyte NADPH oxidase (NOX2) on endosomes and phagosomes [11, 18, 101-103]. Second, cross-presentation is enhanced by targeting antigens – via antibodies or covalent modifications – to receptors that are not efficiently delivered to lysosomes, such as the mannose receptor, DEC205, DNGR-1 or CD40L [17, 102, 104]. Likewise, dead cell uptake through DGNR-1 enhances cross-presentation and retains the phagocytosed corpses in early phagocytic compartments [105, 106]. The results of these studies, however, need to be interpreted with caution. Most of these studies failed to control for the amount of antigen internalized or the kinetics of internalization under the different conditions, which can dramatically impact the availability of antigen; proper use of such a control is best exemplified in studies by the Villadangos laboratory, in which FACS sorting of cells containing single antigen-coated beads [107] excluded variations in antigen uptake. Moreover, the only reliable assay for cross-presentation is stimulation of antigen-specific T cells, which does not always have a suitable dynamic range of response and for which single antigen concentrations are often inappropriately used. Furthermore, a frequently used control for cross-presentation is antigen presentation to MHC-II-restricted T cells, for which the thresholds and sensitivity of the corresponding T cells are not always similar; thus, selective presentation to CD4+ or CD8+ T cells can often be obtained simply by using different concentrations of antigen. Finally, T cell activation is subject to many variables that are difficult to control for, such as cytoskeletal changes and content of adhesion or costimulatory molecules, complicating the use of controls.

ER-phagosome connections

How might antigens escape phagosomes to the cytosol? The best characterized system for export of secretory proteins to the cytosol is retrotranslocation of misfolded proteins from the ER by the ER-associated degradation (ERAD) machinery. If phagocytosed antigens could access this machinery, they could conceivably be translocated just like a misfolded ER protein. The idea that phagosomes can directly recruit ER resident proteins was first proposed by Desjardins and colleagues based on proteomic analyses of purified macrophage phagosomes and associated ultrastructural histochemistry that showed ER membranes in direct continuity with phagosomes or with the plasma membrane [108]. This study proposed that fusion of the ER with the plasma membrane contributed membrane for formation of the phagocytic cup during phagocytosis in macrophages. A limitation of the proteomics data is the potential for contamination of phagosome preparations with very abundant ER-derived membranes. Furthermore, subsequent work using a combination of live-cell imaging and quantitative immunoelectron microscopy challenged the microscopy data, and suggested that fusion of the ER with nascent phagosomes in macrophages was a rare event [109]. Nevertheless, several groups showed that TAP and the peptide-loading complex were recruited and functional on isolated phagosomes in DCs [110-112], making an inferential link of ER-phagosome connections to cross-presentation.

While the morphological and proteomics support for ER-phagosome fusion remain a matter of debate, several groups have provided functional evidence for a requirement for the ER in phagocytosis per se or specifically in cross-presentation. Work in Dictyostelium provided the first functional evidence that ER proteins (i.e. calnexin and calreticulin) are recruited to phagosomes and are required for phagocytosis [113], although the latter could reflect requirements for ER folding of phagosomal proteins. The Cresswell laboratory showed that a peptide bearing an N-glycosylation site and covalently linked to latex beads could be glycosylated after phagocytosis, providing direct evidence for the accessibility of the phagosome lumen to the glycosyltransferase complex of the ER [114]. Importantly, the Rothman laboratory provided evidence for a potential mechanism for ER-phagosome fusion. They identified a fusogenic SNARE complex consisting of the ER v-SNARE Sec22b and the plasma membrane t-SNAREs Syntaxin 18 and Syntaxin 4 [115]. This would potentially allow for fusion of the ER with the plasma membrane or with nascent phagosomes harboring the plasma membrane SNAREs. Several studies that investigated a possible role for ER SNAREs in ER-phagosome interactions in mammalian macrophages confusingly suggested that Syntaxin 18 and Sec22b are positive and negative regulators of phagocytosis, respectively [116-118].

Last year, two studies re-examined the issue. The first one used quantitative proteomics to evaluate the contribution of the ER (and other cellular membranes) to phagosomes in macrophages [119]. These authors found that only a subset of ER resident proteins is actually present in phagosome preparations, and that these ER residents constitute 20% of the protein in early phagosomes. The second study showed that siRNA-mediated knock down of the ER-derived vSNARE Sec22b in DCs inhibits the recruitment of ER resident proteins to phagosomes and severely impairs the efficiency of cross-presentation [120]. This was accompanied by reduced antigen export from phagosomes to the cytosol and increased degradation of phagocytosed antigen. The enrichment of Sec22b in the ER-Golgi intermediate compartment (ERGIC) suggests that in DCs, ERGIC-derived material can fuse directly with phagosomes and thus provide ER proteins required for antigen retrotranslocation and cross-presentation.

A role for ER in cross-presentation is further illustrated in immunity to Toxoplasma gondii. Goldszmid et al. showed that ER proteins are actively recruited to the parasitophorous vacuole harboring live T. gondii but not to phagosomes harboring dead parasites [121]. Concomitantly, T. gondii antigens are presented from live parasites with increased efficiency compared to dead parasites. Moreover, cross-presentation was impaired upon knock down of Sec22b, concomitant with a failure to recruit ER proteins to the parasitophorous vacuole [120]. Thus, recent evidence compellingly supports the recruitment of ER resident proteins to phagosomes and their role in cross-presentation. It will be interesting to explore the requirement for Sec22b in cross-presentation of antigens expressed by other pathogens that manipulate the recruitment of the ER to their vacuoles, such as Legionella or Brucella. Whether ER protein functions in phagosomes extend beyond cross-presentation also remains to be investigated.

Antigen export to the cytosol

Some phagocytosed bacteria, such as Listeria monocytogenes or Salmonella typhimurium, escape phagosomes to the cytosol as part of their life cycle, and can therefore provide sources of MHC-I ligands through the traditional pathway. However, antigens on non-vital bacteria, bacteria that lack such mechanisms, or even internalized proteins can also be efficiently cross-presented as well, suggesting that DCs and other cross-presenting cells must have mechanisms to export phagocytosed antigens to the cytosol.

Rock and colleagues were the first to describe processing of exogenous antigen and cross-presentation by MHC-I in cultured splenocytes [122, 123], and to show that exogenous antigens need to access the cytosol to be cross-presented [124]. Subsequent studies from several groups confirmed that exogenous proteins enter the cytosol for MHC-I presentation. Watts and colleagues reported that exogenous soluble ovalbumin was cross-presented by bone marrow-derived macrophages and DCs in a manner that required proteasome activity and TAP transporters, suggesting that antigen entry into the cytosol was a necessary step during cross-presentation [99, 125]. Finally, morphological (confocal microscopy and EM) and biochemical (subcellular fractionation) data showed that antigens from macropinosomes and phagosomes in DCs, but not macrophages, can be delivered into the cytosol [43, 126]. Export to the cytosol required proteolytic disaggregation of large complexes and was more efficient for low molecular weight cargoes [43]. Two possible mechanisms for this transport were proposed: endosome-phagosome leakage into the cytosol or selective transport through membrane transporters. A recent report provided some support for a leakage mechanism by showing that lipid body function is required during antigen cross-presentation [127]. Lipid bodies were suggested to participate in destabilizing subdomains of the ER or phagosome membrane, thereby causing leakage of their contents [87]. Our recent results, however, show no major defects in antigen export to the cytosol in mice deficient for lipid body biogenesis (Cebrian and Coll, unpublished). Other available evidence supports the existence of a transporter, most likely related to the retranslocation machinery used during ERAD.

ERAD is the main pathway for the degradation of misfolded proteins in the ER by the proteasome [128, 129]. The ERAD machinery consists of a series of E3 ubiquitin ligases and channels that include members of the DERLIN family (but not likely the SEC61 protein import channel, as originally proposed) [130]. Once engaged in the channel, misfolded ER proteins are ubiquitylated and the cytosolic AAA-ATPase VCP/p97 and/or hsp90a promote export to the cytosol. The presence of ER resident proteins in phagosomes led to the early proposal that ERAD could mediate antigen export from phagosomes to the cytosol [114, 131, 132]. Compelling support for this proposal came from the finding that: (i) ExoA, a toxin that inhibits ERAD, also inhibits cross-presentation [114]; (ii) p97 can be co-immunoprecipitated with internalized biotinylated OVA [114]; (iii) interfering with the function or expression of p97 or hsp90 in DCs inhibits cross-presentation [90, 133] and (iv) in vitro reconstituted export from phagosomes requires cytosol or recombinant p97 [134]. In a recent study, Zehner et al. showed a critical role for mannose receptor ubiquitylation in the recruitment of p97 to endosomes and in antigen export to the cytosol [132]. One criticism of these studies is the lack of a reliable quantitative assay for antigen export from endosomes or phagosomes to the cytosol. The assay used for cytosolic export relied on subcellular fractionation, but differential sensitivity of different populations of endosomes or phagosomes to mechanical rupture during cell homogenization could have significantly influenced the results. In addition, the impact of mannose receptors on cross-presentation is still a matter of debate [135-137]. The recent description of a β-lactamase-based assay for cytosolic translocation in living cells may, at least in part, help address these issues in the future [120].

Both ERAD and cytosolic delivery of internalized cargoes require protein unfolding prior to export. Indeed, elegant studies from the Creswell laboratory showed that the ER chaperones BiP, calnexin and calreticulin are present in phagosomes and may participate in protein unfolding [138, 139]. Some antigens additionally require reduction of disulfide bonds during unfolding. In some cases, this might be carried out by ER-associated protein disulfide isomerases. However, it has also been shown that GILT, a protein reductase expressed within endosomal/lysosomal compartments only in professional APCs, plays a critical role in cross-presentation of viral antigens [140, 141], as it does for MHC-II-dependent presentation of disulfide-containing antigens [142].

Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

Just as phagosome formation requires signaling from phagocytic receptors to induce actin and membrane remodeling [1], phagosome maturation and its associated MHC-I/II processing and presentation are also responsive to signaling. Pathogens such as M. tuberculosis interfere with such signaling to arrest phagosome maturation and block both degradative and antigen presenting functions [143]. Innate immunity to microbes relies on the detection of microbial- and danger-derived molecular signatures (collectively named microbial-associated molecular patterns or MAMPs, and danger-associated molecular patterns or DAMPs, respectively) by specific host receptors collectively termed pattern recognition receptors (PRRs) [144, 145]. PRRs include Toll-like receptors (TLRs), Nod-like receptors (NLRs) and C-type lectin receptors such as the mannose receptor, DC-SIGN, dectin-1 and DNGR-1/CLEC9A. C-type lectins detect a variety of common ligands on pathogens or tumor cells including branched oligosaccharides [146] and, for DNGR-1, F-actin released from necrotic cells [147, 148]. Phagocytic receptors for complement and immunoglobulin Fc regions do not strictly represent PRRs but can contribute to pathogen clearance through the engagement of opsonized microbes and cross-talk with PRRs [149, 150], rendering the PRR signaling network even more complex (reviewed in [151] [152]).

The best-studied family of PRRs in the context of phagocytosis and antigen presentation are the TLRs, which in mammals encodes 10–12 membrane-spanning molecules with diverse specificities for extracellular or endosomal MAMPs or DAMPs [153]. Another PRR family, the NLRs, function in the recognition of MAMPs and DAMPs in the cytosol or nuclear compartments [145, 154]. Signaling via PRRs stimulates DC maturation, and concomitantly modulates phagosomal maturation and antigen presentation. The precise mechanisms that link innate sensing, phagosome functions and antigen presentation are not yet clear, but we focus here on studies that address this link at the molecular level.

Innate sensors and antigen processing/presentation by MHC-II

LPS and other TLR ligands stimulate DCs to mature from an antigen sensing form that efficiently internalizes material from the extracellular space to an antigen presenting form that presents this material to T cells in secondary lymphoid organs [155, 156]. A pioneering study by the Mellman group dissociated antigen uptake from antigen processing/ presentation by showing that previously internalized antigens were only effectively presented by MHC-II following treatment of DCs with LPS, correlating with formation of peptide: MHC-II complexes and redistribution of MHC-II from lysosomes to post-lysosomal compartments [82]. Similarly, some activation signals also stimulated cross-presentation of previously internalized antigens by MHC-I [157]. The effect on MHC-II-associated antigen processing is due at least in part to modulation of lysosomal and phagosomal acidification by stimulating the assembly of the vacuolar ATPase complex [158].

The effects of TLR ligation on antigen processing were originally thought to be similar for antigens internalized by phagocytosis or other means. However, the presence of TLRs such as TLR2 and TLR4 on phagosomes suggested that TLR signaling from phagosomes might influence phagosome fate [159, 160]. Indeed, Blander and Medzhitov showed that TLR signaling from within a given phagosome in macrophages or DCs stimulates intrinsic phagosome maturation [66] and antigen processing [67], such that the contents of phagosomes bearing TLR ligands were preferentially presented by MHC-II over those of phagosomes containing apoptotic bodies that were devoid of TLR ligands, even when the two sorts of cargo were internalized by the same cell [67]. We recently reported similar findings regarding distinct antigen degradation and presentation properties of phagosomes in the same cell when one phagosome carried cargoes that cross-link a distinct class of phagocytic and signaling receptor family, the Fc receptor [161]. While the influence of TLR stimulation on phagosome maturation in macrophages has been disputed [162], this property in DCs likely reflects tighter regulation of TLR signaling from phagosomes than from conventional endosomes or the plasma membrane [51, 163], perhaps due to a requirement for more strict checkpoints to trigger an immune response to a live phagocytosed pathogen than to scattered soluble PAMPs [164] or a dead pathogen [165]. Interestingly, in AP-3-deficient DCs, in which recruitment of TLRs to maturing phagosomes is impaired, phagosomes matured normally and processed associated antigens for assembly of MHC-II: peptide complexes [51]. This suggests that signaling from early phagosomes might be sufficient to induce phagosome maturation, perhaps by stimulating engagement of autophagy components [163, 166]. Nevertheless, the MHC-II: peptide complexes that formed in AP-3-deficient DCs remained trapped in intracellular compartments and were not available for presentation at the plasma membrane [51]. These data support the intriguing hypothesis that proinflammatory TLR signaling from phagosomes is required to generate transport intermediates for delivery of MHC-II: peptide complexes to the plasma membrane.

TLRs such as TLR4 stimulate proinflammatory and antiviral signaling via two sets of adaptors: MyD88 and its coadaptor TIRAP/MAL initiate pro-inflammatory responses via MAPK and NFkB activation, whereas TRAM and its coadaptor TRIF stimulate a second phase of proinflammatory response and production of type I interferon via TRAF-dependent IRF3 activation [167, 168]. MyD88-deficient mice have several defects in phagocytosis and phagosome maturation [169-172], suggesting that this pathway is essential for TLR-induced phagosome maturation and downstream antigen presentation [51, 173]. Some reports suggest that MyD88 influences phagosome maturation independently of TLR signaling [162], that TLR signaling inhibits phagosome-lysosome fusion [174], and that prolonged stimulation of TLR2 by M. tuberculosis inhibits MHC-II antigen presentation, at least partially through down-regulation of CIITA activity and reduced MHC-II expression [175, 176]. Interpretation of these results is complicated by defects in inflammasome-dependent IL-1β signaling in MyD88-deficient cells, which could potentially influence phagosomal fate.

NLR engagement can also influence phagosome functions. Recent studies have shown that during infection, two members of the NLR family – Ipaf and Naip5 – restrict Legionella growth by promoting phagosome maturation and intracellular degradation, thereby restricting bacterial growth [177, 178]. Stimulation of NLRP3 has also been shown to enhance maturation of M. tuberculosis-containing phagosomes by activating IL-1β [179]. Although these reports link phagosome function with NLR activation, neither the mechanism of action nor the impact on antigen presentation has been characterized.

Innate sensors and antigen cross-presentation by MHC-I

Whereas TLR ligands clearly activate MHC-II processing and presentation on DCs, the effects of TLR or NLR stimulation on cross-presentation are less clear. Stimulation of several TLRs has been reported to either enhance or antagonize cross-presentation of soluble and particulate antigens on both DCs and macrophages, in some cases with distinct effects depending on whether stimulation occurred prior to or concomitant with Ag exposure [17, 157, 180-191]. In vivo, several reports have shown that cross-presentation can be induced by stimulation through TLRs, including TLR3 and TLR9 [192, 193]. Nevertheless, it is difficult in vivo to distinguish whether T cell priming is increased due to enhanced cross-presentation per se or to increased T cell activation due to DC maturation. More recently, NOD1 and NOD2 agonists have been reported to enhance cross-priming of soluble ovalbumin antigen by CD8+ DCs in vivo and in vitro [194]. This increase, however, might again reflect indirect effects on DC maturation rather than actual stimulation of cross-presentation. By contrast, it has been reported that a NOD2 agonist inhibits the capacity of LPS to increase cross-presentation of viral antigens [180].

Autophagy and MHC Presentation from Phagosomes

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

Autophagy comprises a group of processes by which cytosolic components are delivered to lysosomes for degradation [195, 196]. In particular, macroautophagy refers to the envelopment of cytoplasmic targets by nascent double-membrane compartments called autophagosomes, and subsequent degradation of autophagosome contents upon their fusion with lysosomes. Macroautophagy is thought to proceed at a low constitutive rate in all cells, but can be induced by starvation or other types of cell stress [196]. The interplay of the autophagy pathway with membrane trafficking, organelle dynamics and immunity has become the focus of intensive interest over the past few years, and has been reviewed in detail elsewhere [195-199]. Comments here will be limited to the dual role of autophagy in MHC-I and -II presentation of phagocytosed antigen.

Autophagy and class-II-mediated Ag presentation

The peptides presented on MHC-II molecules primarily derive from the degradation of exogenous antigens. However, endogenous proteins can also be presented by MHC-II molecules; indeed, analysis of peptides eluted from MHC-II molecules in B cells revealed that ∼20% of natural MHC-II ligands are derived from cytosolic and nuclear proteins, including cytoskeletal proteins, heat shock proteins and histones [200, 201]; peptides from cytosolic viral antigens, model antigens and tumor antigens have also been identified [200, 202, 203]. APCs such as B cells, DCs and activated endothelial cells constitutively form autophagosomes that eventually fuse with MIICs [200], providing a constitutive source of cytosolic antigens to the classical MHC-II processing pathway. This mechanism influences presentation of antigens from phagocytosed bacteria in two ways. First, many bacterial pathogens eject virulence factors out of the phagosome and into the host cytosol via specific type III or type IV secretion systems [204, 205]; such virulence factors are critical to bacterial survival and evasion of host cell defenses, but they also provide a source of antigen for MHC-II processing via macroautophagy. For example, infection by Yersinia pseudotuberculosis impairs antigen uptake and classical MHC-II processing by macrophages, but infected cells are still capable of stimulating CD4+ T cells specific for the outer membrane protein YopE, a substrate of the Yersinia type III secretion system [206]. MHC-II presentation of YopE is sensitive to inhibitors of autophagy and of lysosomal proteolysis, suggesting that YopE encounters MHC-II molecules in classical MIIC following autophagy. A second role for autophagy in recovering phagosomal antigens applies to bacteria such as Salmonella typhimurium and Listeria monocytogenes that escape the encapsulating phagosome into the cytosol as a pathogen strategy to avoid lysosomal degradation [207]. Macroautophagy provides a mechanism to sequester these escaped bacterial forms and protect the host from uncontrolled bacterial replication [208-211]. Similarly, group A Streptococcus that accesses the cytosol in non-phagocytic cell types is also controlled by lysosomal degradation following autophagy [212]. By delivering cytosolic bacteria to lysosomes independently of phagosome maturation, autophagy provides a ‘second chance’ for generating peptides for presentation by MHC-II. Indeed, CD4+ T cell immune responses to M. tuberculosis – a pathogen that similarly escapes phagosomes [106] – were enhanced upon stimulation of autophagy and inhibited upon interference with autophagy [213] (although this might occur by a different mechanism – see below). Hence, autophagy is an attractive pathway to counteract pathogen evasion of both innate and adaptive cellular immunity.

While macroautophagy provides a venue for MHC-II access to cytoplasmic proteins that derive from phagosomes, it also appears that autophagy regulators independently facilitate phagosome maturation to phagolysosomes. This was first recognized during infection of macrophages with mycobacteria, as M. tuberculosis has long been known to arrest phagosome maturation to evade destruction [214]. Pharmacological and physiological induction of autophagy in cells infected with the attenuated BCG strain overcomes the normal phagosome maturation arrest and results in effective phagolysosome formation [215]. This might explain the enhanced MHC-II presentation of bacterial peptides upon stimulation of autophagy in M. tuberculosis-infected macrophages and DCs [213]. A requirement for autophagy components in phagosome maturation is not limited to M. tuberculosis phagosomes. Autophagy effectors such as LC3 and Beclin 1 have been shown to be recruited to phagosomes containing bacteria, yeast, LPS-coated latex beads, apoptotic cells and entotic vacuoles [166, 216, 217], and depletion of ATG5 or ATG7 blocks phagosome acidification and content degradation [166]. Moreover, Atg5−/− DCs show impaired processing of phagocytosed antigen due to diminished phagosome maturation, leading to decreased presentation by MHC-II [163], and DCs depleted of autophagy mediators ATG5, ATG7 or ATG16L1 are impaired in controlling bacterial growth and antigen presentation upon infection with Salmonella enterica or E. coli [218]. MAMP recognition by many members of the TLR and NLR family can trigger both autophagy and LC3-associated phagosomes [216, 219], perhaps in part explaining the stimulation of phagosome maturation induced by TLRs and other PRRs. The link between PRR stimulation, autophagy and phagosome maturation is clinically important, as polymorphisms in the NLR NOD2 and the autophagy regulator ATG16L1 have been linked to Crohn's disease, an inflammatory disease in which tolerance to commensal bacteria is dysregulated [218, 220]. Together, these findings all point to a joint effort between phagocytosis and autophagy in the route to pathogen clearance and antigen processing.

Autophagy and MHC-I-restricted antigen presentation

To date, autophagy has been implicated in the classical MHC-I presentation pathway in only one report, focusing on the processing and presentation of the cytosolic HSV-1 protein gB; Desjardins and colleagues showed that upon infection by HSV-1, macrophages depleted of ATG5 have a reduced capacity compared to WT macrophages to stimulate a gB-specific CD8+ T cell response [221]. A role for autophagy in cross-presentation of phagocytosed antigens has been more controversial. One report showed that antigens conjugated to alpha-alumina nanoparticles are efficiently cross-presented by an ATG12-independent autophagy pathway [222]. They reported that siRNA knockdown of ATG6, but not ATG12, impaired cross-presentation of ovalbumin coupled to these nanoparticles. The influence of ATG6 on cross-presentation from nanoparticles, however, might reflect a property of the nanoparticles themselves rather than a general requirement for autophagy in cross-presentation from phagosomes. For example, whereas treatment of DCs with the autophagy/phosphatidylinositol(3)kinase inhibitors 3-methyladenine (3-MA; blocks early stages of autophagy and LC3-associated phagosome maturation) or wortmannin abolished cross-presentation of ovalbumin coupled to alpha-alumina nanoparticles (but not of soluble ovalbumin) [222], treatment with 3-MA had no effect on cross-presentation of HIV-1 antigens to HIV-specific CD8+ T cell clones [223]. In addition, it has been reported that Atg5-deficient DCs cross-presented both apoptotic cell-associated and soluble ovalbumin normally [163].

While a generalized role in cross-presentation is unclear, autophagy has been reported to play a role in antigen packaging in donor cells for efficient cross-presentation from dead or dying cells by DCs. In one study, cross-presentation of an expressed model antigen or an endogenous tumor antigen following coculture with DCs was enhanced when the donor cells were exposed to treatments that stimulate macroautophagy (rapamycin or starvation) and antagonized by treatment with inhibitors of macroautophagy (3-MA or wortmannin) [224]. Moreover, cross-presentation of the gp100 tumor antigen was impaired when ATG6 or ATG12 were knocked down in donor melanoma cells, and isolated autophagosomes were able to directly provide antigen to DCs. In a second study, an influenza A virus antigen was more efficiently cross-presented by DCs exposed to infected fibroblasts from Bax/Bak−/− mice, which exhibit increased features of autophagy, than from wild-type mice, and this enhancement was largely abolished by siRNA-silencing of ATG5 [225]. While these studies establish a clear role for macroautophagy in the antigenicity of dying cells for cross-presentation, the mechanisms involved remain unclear.

Conclusion

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

The last 15 years have witnessed an impressive expansion in our appreciation of phagosomes as specialized compartments for antigen processing and presentation. Once considered only a degradative compartment devoted to the killing of engulfed microbes, phagosomes have emerged as sophisticated platforms that integrate antigen processing with innate signaling, providing a molecular link between innate sensors and the generation of ligands for antigen receptors. Understanding how signaling from phagosomes affects phagosomal functions, and the consequences of phagosomal signaling on antigen processing and presentation, represents a challenge for the development of effective vaccination strategies.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

This work was supported by National Institutes of Health grant AI92398 from the National Institute of Allergy and Infectious Diseases, INSERM, Institut Curie, the European Research Council (2008 Advanced Grant 233062 PhagoDC), la Ligue Nationale Contre le Cancer (LNCC) and l'Agence Nationale de la Recherche. J. G. M. received funding from Fondation Recherche Medical. The authors declare no conflict of interest.

References

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure
  • 1
    Flannagan RS, Jaumouille V, Grinstein S. The cell biology of phagocytosis. Annu Rev Pathol 2012;7:6198.
  • 2
    Swanson JA. Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol 2008;9:639649.
  • 3
    Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009;7:355366.
  • 4
    Kinchen JM, Ravichandran KS. Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol 2008;9:781795.
  • 5
    Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 2007;219:143156.
  • 6
    Ramachandra L, Simmons D, Harding CV. MHC molecules and microbial antigen processing in phagosomes. Curr Opin Immunol 2009;21:98104.
  • 7
    Gordon S. Elie Metchnikoff: father of natural immunity. Eur J Immunol 2008;38:32573264.
  • 8
    Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:11421162.
  • 9
    Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298300.
  • 10
    Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008;322:10971100.
  • 11
    Savina A, Peres A, Cebrian I, Carmo N, Moita C, Hacohen N, Moita LF, Amigorena S. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 2009;30:544555.
  • 12
    Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821850.
  • 13
    Ziegler K, Unanue ER. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol 1981;127:18691875.
  • 14
    Harding CV, Geuze HJ. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 1992;119:531542.
  • 15
    Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993;178:479488.
  • 16
    Pancholi P, Mirza A, Schauf V, Steinman RM, Bhardwaj N. Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages. Infect Immun 1993;61:53265332.
  • 17
    Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008;9:558566.
  • 18
    Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Dumenil AM, Seabra MC, Raposo G, Amigorena S. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006;126:205218.
  • 19
    Cresswell P. Invariant chain structure and MHC class II function. Cell 1996;84:505507.
  • 20
    Roche PA, Teletski CL, Stang E, Bakke O, Long EO. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 1993;90:85818585.
  • 21
    McCormick PJ, Martina JA, Bonifacino JS. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc Natl Acad Sci USA 2005;102:79107915.
  • 22
    Warmerdam PA, Long EO, Roche PA. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 1996;133:281291.
  • 23
    Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669676.
  • 24
    Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992;360:474477.
  • 25
    Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995;82:155165.
  • 26
    Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996;15:61446154.
  • 27
    Wubbolts R, Fernandez-Borja M, Oomen L, Verwoerd D, Janssen H, Calafat J, Tulp A, Dusseljee S, Neefjes J. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 1996;135:611622.
  • 28
    Boes M, Cerny J, Massol R, Op den Brouw M, Kirchhausen T, Chen J, Ploegh HL. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 2002;418:983988.
  • 29
    Chow A, Toomre D, Garrett W, Mellman I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 2002;418:988994.
  • 30
    Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995;375:603606.
  • 31
    Harding CV. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules. Semin Immunol 1995;7:355360.
  • 32
    Hartman IZ, Kim A, Cotter RJ, Walter K, Dalai SK, Boronina T, Griffith W, Lanar DE, Schwenk R, Krzych U, Cole RN, Sadegh-Nasseri S. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nat Med 2010;16:13331340.
  • 33
    Peters PJ, Raposo G, Neefjes JJ, Oorschot V, Leijendekker RL, Geuze HJ, Ploegh HL. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med 1995;182:325334.
  • 34
    Nijman HW, Kleijmeer MJ, Ossevoort MA, Oorschot VM, Vierboom MP, van de Keur M, Kenemans P, Kast WM, Geuze HJ, Melief CJ. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med 1995;182:163174.
  • 35
    Kleijmeer MJ, Ossevoort MA, van Veen CJ, van Hellemond JJ, Neefjes JJ, Kast WM, Melief CJ, Geuze HJ. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J Immunol 1995;154:57155724.
  • 36
    Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011;11:823836.
  • 37
    Potolicchio I, Chitta S, Xu X, Fonseca D, Crisi G, Horejsi V, Strominger JL, Stern LJ, Raposo G, Santambrogio L. Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC. J Immunol 2005;175:49354947.
  • 38
    ten Broeke T, van Niel G, Wauben MH, Wubbolts R, Stoorvogel W. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 2011;12:10251036.
  • 39
    Peaper DR, Cresswell P. Regulation of MHC class I assembly and peptide binding. Annu Rev Cell Dev Biol 2008;24:343368.
  • 40
    Yewdell JW. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011;32:548558.
  • 41
    Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007;37:S53S60.
  • 42
    Segura E, Villadangos JA. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic 2011;12:16771685.
  • 43
    Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat Cell Biol 1999;1:362368.
  • 44
    Amigorena S, Savina A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 2010;22:109117.
  • 45
    Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E, Addey C, Scott D, Dyson J, Simpson E, Cerundolo V. Role of immunoproteasomes in cross-presentation. J Immunol 2006;177:983990.
  • 46
    Ramachandra L, Song R, Harding CV. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. J Immunol 1999;162:32633272.
  • 47
    Ramachandra L, Noss E, Boom WH, Harding CV. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J Exp Med 2001;194:14211432.
  • 48
    von Delwig A, Ramachandra L, Harding CV, Robinson JH. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes. Eur J Immunol 2003;33:23532360.
  • 49
    Murphy DB, Rath S, Pizzo E, Rudensky AY, George A, Larson JK, Janeway CA Jr. Monoclonal antibody detection of a major self peptide. MHC class II complex. J Immunol 1992;148:34833491.
  • 50
    Rudensky A, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA Jr. On the complexity of self. Nature 1991;353:660662.
  • 51
    Mantegazza AR, Guttentag SH, El-Benna J, Sasai M, Iwasaki A, Shen H, Laufer TM, Marks MS. Adaptor protein-3 in dendritic cells facilitates phagosomal Toll-like receptor signaling and antigen presentation to CD4(+) T cells. Immunity 2012;36:782794.
  • 52
    Muraille E, Gounon P, Cazareth J, Hoebeke J, Lippuner C, Davalos-Misslitz A, Aebischer T, Muller S, Glaichenhaus N, Mougneau E. Direct visualization of peptide/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major. PLoS Pathog 2010;6:e1001154.
  • 53
    Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990;63:707716.
  • 54
    Romagnoli P, Layet C, Yewdell J, Bakke O, Germain RN. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 1993;177:583596.
  • 55
    Simonsen A, Momburg F, Drexler J, Hammerling GJ, Bakke O. Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int Immunol 1993;5:903917.
  • 56
    Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 2003;72:395447.
  • 57
    Kongsvik TL, Honing S, Bakke O, Rodionov DG. Mechanism of interaction between leucine-based sorting signals from the invariant chain and clathrin-associated adaptor protein complexes AP1 and AP2. J Biol Chem 2002;277:1648416488.
  • 58
    Dugast M, Toussaint H, Dousset C, Benaroch P. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J Biol Chem 2005;280:1965619664.
  • 59
    Dell'Angelica EC. AP-3-dependent trafficking and disease: the first decade. Curr Opin Cell Biol 2009;21:552559.
  • 60
    Caplan S, Dell'Angelica EC, Gahl WA, Bonifacino JS. Trafficking of major histocompatibility complex class II molecules in human B-lymphoblasts deficient in the AP-3 adaptor complex. Immunol Lett 2000;72:113117.
  • 61
    Sevilla LM, Richter SS, Miller J. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice. Cell Immunol 2001;210:143153.
  • 62
    Vascotto F, Lankar D, Faure-Andre G, Vargas P, Diaz J, Le Roux D, Yuseff MI, Sibarita JB, Boes M, Raposo G, Mougneau E, Glaichenhaus N, Bonnerot C, Manoury B, Lennon-Dumenil AM. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J Cell Biol 2007;176:10071019.
  • 63
    Ikonen E, de Almeid JB, Fath KR, Burgess DR, Ashman K, Simons K, Stow JL. Myosin II is associated with Golgi membranes: identification of p200 as nonmuscle myosin II on Golgi-derived vesicles. J Cell Sci 1997;110:21552164.
  • 64
    Musch A, Cohen D, Rodriguez-Boulan E. Myosin II is involved in the production of constitutive transport vesicles from the TGN. J Cell Biol 1997;138:291306.
  • 65
    Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D, Albert M, Bhardwaj N, Mellman I, Steinman RM. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998;188:21632173.
  • 66
    Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from Toll-like receptors. Science 2004;304:10141018.
  • 67
    Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006;440:808812.
  • 68
    Ullrich HJ, Beatty WL, Russell DG. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J Immunol 2000;165:60736080.
  • 69
    Garg S, Sharma M, Ung C, Tuli A, Barral DC, Hava DL, Veerapen N, Besra GS, Hacohen N, Brenner MB. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity 2011;35:182193.
  • 70
    Hava DL, van der Wel N, Cohen N, Dascher CC, Houben D, Leon L, Agarwal S, Sugita M, van Zon M, Kent SC, Shams H, Peters PJ, Brenner MB. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc Natl Acad Sci USA 2008;105:1128111286.
  • 71
    Lapaque N, Jahnke M, Trowsdale J, Kelly AP. The HLA-DRalpha chain is modified by polyubiquitination. J Biol Chem 2009;284:70077016.
  • 72
    De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci USA 2008;105:34913496.
  • 73
    Matsuki Y, Ohmura-Hoshino M, Goto E, Aoki M, Mito-Yoshida M, Uematsu M, Hasegawa T, Koseki H, Ohara O, Nakayama M, Toyooka K, Matsuoka K, Hotta H, Yamamoto A, Ishido S. Novel regulation of MHC class II function in B cells. EMBO J 2007;26:846854.
  • 74
    Shin JS, Ebersold M, Pypaert M, Delamarre L, Hartley A, Mellman I. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 2006;444:115118.
  • 75
    van Niel G, Wubbolts R, ten Broeke T, Buschow SI, Ossendorp FA, Melief CJ, Raposo G, van Balkom BW, Stoorvogel W. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 2006;25:885894.
  • 76
    Walseng E, Furuta K, Bosch B, Weih KA, Matsuki Y, Bakke O, Ishido S, Roche PA. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc Natl Acad Sci USA 2010;107:2046520470.
  • 77
    Lapaque N, Hutchinson JL, Jones DC, Méresse S, Holden DW, Trowsdale J, Kelly AP. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc Natl Acad Sci USA 2009;106:1405214057.
  • 78
    Wilson JE, Katkere B, Drake JR. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect Immun 2009;77:49534965.
  • 79
    Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, Ploegh H. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner. J Immunol 2003;171:40814088.
  • 80
    Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:11611172.
  • 81
    Kleijmeer M, Ramm G, Schuurhuis D, Griffith J, Rescigno M, Ricciardi-Castagnoli P, Rudensky AY, Ossendorp F, Melief CJ, Stoorvogel W, Geuze HJ. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 2001;155:5363.
  • 82
    Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 2000;288:522527.
  • 83
    Wubbolts R, Fernandez-Borja M, Jordens I, Reits E, Dusseljee S, Echeverri C, Vallee RB, Neefjes J. Opposing motor activities of dynein and kinesin determine retention and transport of MHC class II-containing compartments. J Cell Sci 1999;112:785795.
  • 84
    Pond L, Watts C. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. J Immunol 1997;159:543553.
  • 85
    Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787792.
  • 86
    Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782787.
  • 87
    Vyas JM, Kim YM, Artavanis-Tsakonas K, Love JC, Van der Veen AG, Ploegh HL. Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells. J Immunol 2007;178:71997210.
  • 88
    Rocha N, Neefjes J. MHC class II molecules on the move for successful antigen presentation. EMBO J 2008;27:15.
  • 89
    Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009;10:513525.
  • 90
    Imai T, Kato Y, Kajiwara C, Mizukami S, Ishige I, Ichiyanagi T, Hikida M, Wang JY, Udono H. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc Natl Acad Sci USA 2011;108:1636316368.
  • 91
    Chavrier P, Parton RG, Hauri HP, Simons K, Zerial M. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 1990;62:317329.
  • 92
    Bertram EM, Hawley RG, Watts TH. Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells. Int Immunol 2002;14:309318.
  • 93
    Jordens I, Fernandez-Borja M, Marsman M, Dusseljee S, Janssen L, Calafat J, Janssen H, Wubbolts R, Neefjes J. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 2001;11:16801685.
  • 94
    Johansson M, Rocha N, Zwart W, Jordens I, Janssen L, Kuijl C, Olkkonen VM, Neefjes J. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. J Cell Biol 2007;176:459471.
  • 95
    Paul P, van den Hoorn T, Jongsma ML, Bakker MJ, Hengeveld R, Janssen L, Cresswell P, Egan DA, van Ham M, Ten Brinke A, Ovaa H, Beijersbergen RL, Kuijl C, Neefjes J. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 2011;145:268283.
  • 96
    Mao YS, Yamaga M, Zhu X, Wei Y, Sun HQ, Wang J, Yun M, Wang Y, Di Paolo G, Bennett M, Mellman I, Abrams CS, De Camilli P, Lu CY, Yin HL. Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. J Cell Biol 2009;184:281296.
  • 97
    Bohdanowicz M, Grinstein S. Vesicular traffic: a Rab SANDwich. Curr Biol 2010;20:R311R314.
  • 98
    Harding CV, Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 1994;153:49254933.
  • 99
    Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997;27:280288.
  • 100
    Accapezzato D, Visco V, Francavilla V, Molette C, Donato T, Paroli M, Mondelli MU, Doria M, Torrisi MR, Barnaba V. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med 2005;202:817828.
  • 101
    Graham DB, Stephenson LM, Lam SK, Brim K, Lee HM, Bautista J, Gilfillan S, Akilesh S, Fujikawa K, Swat W. An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J Exp Med 2007;204:28892897.
  • 102
    Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, Dang PM, Pascolo S, Gougerot-Pocidalo MA, Raposo G, Seabra MC, Amigorena S. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 2007;9:367378.
  • 103
    Mantegazza AR, Savina A, Vermeulen M, Perez L, Geffner J, Hermine O, Rosenzweig SD, Faure F, Amigorena S. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 2008;112:47124722.
  • 104
    Chatterjee B, Smed-Sorensen A, Cohn L, Chalouni C, Vandlen R, Lee BC, Widger J, Keler T, Delamarre L, Mellman I. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 2012;120:20112020.
  • 105
    Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz-Falcon P, Rosewell I, Reis e Sousa C. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009;458:899903.
  • 106
    Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, Rogers NC, Schulz O, Sancho D, Reis e Sousa C. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 2012;122:16151627.
  • 107
    Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, El-Sukkari D, Davey G, Kupresanin F, Li M, Maraskovsky E, Belz GT, Carbone FR, Shortman K, Heath WR, Villadangos JA. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 2006;103:1072910734.
  • 108
    Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O, Paiement J, Bergeron JJ, Desjardins M. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002;110:119131.
  • 109
    Touret N, Paroutis P, Terebiznik M, Harrison RE, Trombetta S, Pypaert M, Chow A, Jiang A, Shaw J, Yip C, Moore HP, van der Wel N, Houben D, Peters PJ, de Chastellier C, et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 2005;123:157170.
  • 110
    Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A, Princiotta MF, Thibault P, Sacks D, Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003;425:402406.
  • 111
    Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003;425:397402.
  • 112
    Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci USA 2003;100:1288912894.
  • 113
    Muller-Taubenberger A, Lupas AN, Li H, Ecke M, Simmeth E, Gerisch G. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J 2001;20:67726782.
  • 114
    Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006;25:607617.
  • 115
    Parlati F, McNew JA, Fukuda R, Miller R, Sollner TH, Rothman JE. Topological restriction of SNARE-dependent membrane fusion. Nature 2000;407:194198.
  • 116
    Becker T, Volchuk A, Rothman JE. Differential use of endoplasmic reticulum membrane for phagocytosis in J774 macrophages. Proc Natl Acad Sci USA 2005;102:40224026.
  • 117
    Hatsuzawa K, Tamura T, Hashimoto H, Yokoya S, Miura M, Nagaya H, Wada I. Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis. Mol Biol Cell 2006;17:39643977.
  • 118
    Hatsuzawa K, Hashimoto H, Arai S, Tamura T, Higa-Nishiyama A, Wada I. Sec22b is a negative regulator of phagocytosis in macrophages. Mol Biol Cell 2009;20:44354443.
  • 119
    Campbell-Valois FX, Trost M, Chemali M, Dill BD, Laplante A, Duclos S, Sadeghi S, Rondeau C, Morrow IC, Bell C, Gagnon E, Hatsuzawa K, Thibault P, Desjardins M. Quantitative proteomics reveals that only a subset of the endoplasmic reticulum contributes to the phagosome. Mol Cell Proteomics 2012;11:M111.016378.
  • 120
    Cebrian I, Visentin G, Blanchard N, Jouve M, Bobard A, Moita C, Enninga J, Moita LF, Amigorena S, Savina A. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 2011;147:13551368.
  • 121
    Goldszmid RS, Coppens I, Lev A, Caspar P, Mellman I, Sher A. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J Exp Med 2009;206:399410.
  • 122
    Rock KL, Gamble S, Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 1990;249:918921.
  • 123
    Rock KL, Rothstein L, Gamble S, Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 1993;150:438446.
  • 124
    Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243246.
  • 125
    Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995;3:783791.
  • 126
    Watts C. Phagocytosis: how the phagosome became the phag-ER-some. Curr Biol 2002;12:R666R668.
  • 127
    Bougneres L, Helft J, Tiwari S, Vargas P, Chang BH, Chan L, Campisi L, Lauvau G, Hugues S, Kumar P, Kamphorst AO, Dumenil AM, Nussenzweig M, MacMicking JD, Amigorena S, et al. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity 2009;31:232244.
  • 128
    Vembar SS, Brodsky JL. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 2008;9:944957.
  • 129
    Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol 2005;7:766772.
  • 130
    Smith MH, Ploegh HL, Weissman JS. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 2011;334:10861090.
  • 131
    Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996;384:432438.
  • 132
    Zehner M, Chasan AI, Schuette V, Embgenbroich M, Quast T, Kolanus W, Burgdorf S. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc Natl Acad Sci USA 2011;108:99339938.
  • 133
    Ichiyanagi T, Imai T, Kajiwara C, Mizukami S, Nakai A, Nakayama T, Udono H. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation. J Immunol 2010;185:26932700.
  • 134
    Giodini A, Cresswell P. Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells. EMBO J 2008;27:201211.
  • 135
    Burgdorf S, Lukacs-Kornek V, Kurts C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol 2006;176:67706776.
  • 136
    Burgdorf S, Schuette V, Semmling V, Hochheiser K, Lukacs-Kornek V, Knolle PA, Kurts C. Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments. Proc Natl Acad Sci USA 2010;107:E48E49 author reply E50–41.
  • 137
    Segura E, Albiston AL, Wicks IP, Chai SY, Villadangos JA. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci USA 2009;106:2037720381.
  • 138
    Diedrich G, Bangia N, Pan M, Cresswell P. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. J Immunol 2001;166:17031709.
  • 139
    Zhu Y, Zhang W, Veerapen N, Besra G, Cresswell P. Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulum. J Biol Chem 2010;285:3828338292.
  • 140
    Singh R, Cresswell P. Defective cross-presentation of viral antigens in GILT-free mice. Science 2010;328:13941398.
  • 141
    Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, Cresswell P. Defective antigen processing in GILT-free mice. Science 2001;294:13611365.
  • 142
    Hastings KT, Cresswell P. Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase. Antioxid Redox Signal 2011;15:657668.
  • 143
    Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 2010;8:296307.
  • 144
    Kimbrell DA, Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2001;2:256267.
  • 145
    Werts C, Girardin SE, Philpott DJ. TIR, CARD and PYRIN: three domains for an antimicrobial triad. Cell Death Differ 2006;13:798815.
  • 146
    Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012;30:491529.
  • 147
    Ahrens S, Zelenay S, Sancho D, Hanc P, Kjaer S, Feest C, Fletcher G, Durkin C, Postigo A, Skehel M, Batista F, Thompson B, Way M, Reis e Sousa C, Schulz O. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012;36:635645.
  • 148
    Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, Tullett KM, Robin AY, Brammananth R, van Delft MF, Lu J, O'Reilly LA, Josefsson EC, Kile BT, Chin WJ, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012;36:646657.
  • 149
    Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, Werner CM, Wanner GA, Simmen HP, Huber-Lang MS, Ward PA. Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog 2009;5:e1000464.
  • 150
    van Lookeren Campagne M, Wiesmann C, Brown EJ. Macrophage complement receptors and pathogen clearance. Cell Microbiol 2007;9:20952102.
  • 151
    O'Neill LA. When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 2008;29:1220.
  • 152
    Mukhopadhyay S, Herre J, Brown GD, Gordon S. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 2004;112:521530.
  • 153
    Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005;17:338344.
  • 154
    Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG, Nunez G. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 2008;10:18.
  • 155
    Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621667.
  • 156
    Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987995.
  • 157
    Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003;198:111122.
  • 158
    Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003;299:14001403.
  • 159
    Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999;401:811815.
  • 160
    Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 2010;33:583596.
  • 161
    Hoffmann E, Kotsias F, Visentin G, Bruhns P, Savina A, Amigorena S. Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proc Natl Acad Sci USA 2012;109:1455614561.
  • 162
    Yates RM, Russell DG. Phagosome maturation proceeds independently of stimulation of Toll-like receptors 2 and 4. Immunity 2005;23:409417.
  • 163
    Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, Mizushima N, Grinstein S, Iwasaki A. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010;32:227239.
  • 164
    Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 2009;6:1021.
  • 165
    Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol 2012;12:215225.
  • 166
    Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, Green DR. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007;450:12531257.
  • 167
    Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008;9:361368.
  • 168
    Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637650.
  • 169
    de Veer MJ, Curtis JM, Baldwin TM, DiDonato JA, Sexton A, McConville MJ, Handman E, Schofield L. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 2003;33:28222831.
  • 170
    Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 2002;169:39703977.
  • 171
    Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 2004;72:31953203.
  • 172
    Marr KA, Balajee SA, Hawn TR, Ozinsky A, Pham U, Akira S, Aderem A, Liles WC. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun 2003;71:52805286.
  • 173
    Arpaia N, Godec J, Lau L, Sivick KE, McLaughlin LM, Jones MB, Dracheva T, Peterson SN, Monack DM, Barton GM. TLR signaling is required for Salmonella typhimurium virulence. Cell 2011;144:675688.
  • 174
    Shiratsuchi A, Watanabe I, Takeuchi O, Akira S, Nakanishi Y. Inhibitory effect of Toll-like receptor 4 on fusion between phagosomes and endosomes/lysosomes in macrophages. J Immunol 2004;172:20392047.
  • 175
    Wojciechowski W, DeSanctis J, Skamene E, Radzioch D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J Immunol 1999;163:26882696.
  • 176
    Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol 2006;176:43234330.
  • 177
    Amer A, Franchi L, Kanneganti TD, Body-Malapel M, Ozoren N, Brady G, Meshinchi S, Jagirdar R, Gewirtz A, Akira S, Nunez G. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J Biol Chem 2006;281:3521735223.
  • 178
    Fortier A, de Chastellier C, Balor S, Gros P. Birc1e/Naip5 rapidly antagonizes modulation of phagosome maturation by Legionella pneumophila. Cell Microbiol 2007;9:910923.
  • 179
    Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 2008;3:224232.
  • 180
    Wagner CS, Cresswell P. TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J Immunol 2012;188:686693.
  • 181
    Matsuo M, Nagata Y, Sato E, Atanackovic D, Valmori D, Chen YT, Ritter G, Mellman I, Old LJ, Gnjatic S. IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proc Natl Acad Sci USA 2004;101:1446714472.
  • 182
    Matheoud D, Perie L, Hoeffel G, Vimeux L, Parent I, Maranon C, Bourdoncle P, Renia L, Prevost-Blondel A, Lucas B, Feuillet V, Hosmalin A. Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo. Blood 2010;115:44124420.
  • 183
    Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, Young L, Forehan SP, Mount A, Steptoe RJ, Shortman KD, de Koning-Ward TF, Belz GT, Carbone FR, Crabb BS, Heath WR, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 2006;7:165172.
  • 184
    Gil-Torregrosa BC, Lennon-Dumenil AM, Kessler B, Guermonprez P, Ploegh HL, Fruci D, van Endert P, Amigorena S. Control of cross-presentation during dendritic cell maturation. Eur J Immunol 2004;34:398407.
  • 185
    Weck MM, Grunebach F, Werth D, Sinzger C, Bringmann A, Brossart P. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 2007;109:38903894.
  • 186
    Henri S, Siret C, Machy P, Kissenpfennig A, Malissen B, Leserman L. Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen. Eur J Immunol 2007;37:11841193.
  • 187
    Machy P, Serre K, Leserman L. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur J Immunol 2000;30:848857.
  • 188
    Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RA, Mellman I, Delamarre L. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci USA 2010;107:42874292.
  • 189
    Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tallant T, DiDonato J, Dziarski R, Akira S, Schoenberger SP, Raz E. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 2003;170:41024110.
  • 190
    Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, Amigorena S. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999;189:371380.
  • 191
    Drutman SB, Trombetta ES. Dendritic cells continue to capture and present antigens after maturation in vivo. J Immunol 2010;185:21402146.
  • 192
    Datta SK, Raz E. Induction of antigen cross-presentation by Toll-like receptors. Springer Semin Immunopathol 2005;26:247255.
  • 193
    Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljestrom P, Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005;433:887892.
  • 194
    Asano J, Tada H, Onai N, Sato T, Horie Y, Fujimoto Y, Fukase K, Suzuki A, Mak TW, Ohteki T. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J Immunol 2010;184:736745.
  • 195
    Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008;451:10691075.
  • 196
    Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010;12:814822.
  • 197
    Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 2011;80:125156.
  • 198
    Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469:323335.
  • 199
    Crotzer VL, Blum JS. Cytosol to lysosome transport of intracellular antigens during immune surveillance. Traffic 2008;9:1016.
  • 200
    Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007;26:7992.
  • 201
    Costantino CM, Spooner E, Ploegh HL, Hafler DA. Class II MHC self-antigen presentation in human B and T lymphocytes. PLoS One 2012;7:e29805.
  • 202
    Nimmerjahn F, Milosevic S, Behrends U, Jaffee EM, Pardoll DM, Bornkamm GW, Mautner J. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur J Immunol 2003;33:12501259.
  • 203
    Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, Munz C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005;307:593596.
  • 204
    Fronzes R, Christie PJ, Waksman G. The structural biology of type IV secretion systems. Nat Rev Microbiol 2009;7:703714.
  • 205
    Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 2009;7:654665.
  • 206
    Russmann H, Panthel K, Kohn B, Jellbauer S, Winter SE, Garbom S, Wolf-Watz H, Hoffmann S, Grauling-Halama S, Geginat G. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation. Infect Immun 2010;78:51385150.
  • 207
    Huang J, Brumell JH. Autophagy in immunity against intracellular bacteria. Curr Top Microbiol Immunol 2009;335:189215.
  • 208
    Wolf AJ, Arruda A, Reyes CN, Kaplan AT, Shimada T, Shimada K, Arditi M, Liu G, Underhill DM. Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J Immunol 2011;187:60026010.
  • 209
    Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 2009;10:12151221.
  • 210
    Yano T, Mita S, Ohmori H, Oshima Y, Fujimoto Y, Ueda R, Takada H, Goldman WE, Fukase K, Silverman N, Yoshimori T, Kurata S. Autophagic control of listeria through intracellular innate immune recognition in drosophila. Nat Immunol 2008;9:908916.
  • 211
    Py BF, Lipinski MM, Yuan J. Autophagy limits Listeria monocytogenes intracellular growth in the early phase of primary infection. Autophagy 2007;3:117125.
  • 212
    Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. Autophagy defends cells against invading group A Streptococcus. Science 2004;306:10371040.
  • 213
    Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 2009;15:267276.
  • 214
    Vergne I, Chua J, Singh SB, Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu Rev Cell Dev Biol 2004;20:367394.
  • 215
    Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004;119:753766.
  • 216
    Florey O, Overholtzer M. Autophagy proteins in macroendocytic engulfment. Trends Cell Biol 2012;22:374380.
  • 217
    Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P, Hengartner MO, Green DR. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci USA 2011;108:1739617401.
  • 218
    Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010;16:9097.
  • 219
    Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev 2011;240:92104.
  • 220
    Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG, Yuan L, Soares F, Chea E, Le Bourhis L, Boneca IG, Allaoui A, Jones NL, Nunez G, Girardin SE, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010;11:5562.
  • 221
    English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, Alexander D, Leib D, Norbury C, Lippe R, Desjardins M. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009;10:480487.
  • 222
    Li H, Li Y, Jiao J, Hu HM. Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol 2011;6:645650.
  • 223
    Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R, Garcia E, Dinkins C, Leuba F, Wu L, Schwartz O, Deretic V, Piguet V. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 2010;32:654669.
  • 224
    Li Y, Wang LX, Yang G, Hao F, Urba WJ, Hu HM. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008;68:68896895.
  • 225
    Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 2009;16:9911005.

Appendix 1.: Abstract figure

  1. Top of page
  2. Abstract
  3. Processing and Presentation of Phagocytosed Antigens by MHC-I and -II
  4. Phagosomes as Antigen Presentation Compartments
  5. Innate Signaling Controls Phagosome Maturation and Antigen Processing/Presentation
  6. Autophagy and MHC Presentation from Phagosomes
  7. Conclusion
  8. Acknowledgements
  9. References
  10. Appendix 1.: Abstract figure

Presentation of phagocytosed antigens by MHC class I and II. In this review, we focus on the cell biological aspects of antigen presentation through the eyes of phagocytes that take up large foreign particles through the process of phagocytosis. We focus on two distinct antigen processing pathways for presentation by MHC class I (MHC-I) and MHC class II (MHCII) molecules. In this figure, we summarize the two main proposed models for intracellular pathways leading to cross-presentation of phagocytosed antigens by MHC-I in dendritic cells. Left, the TAP- and proteasome-dependent cytosolic pathway. In this scenario, antigens on phagocytosed particles are exported to the cytosol by an ERAD-associated retrotranslocon, ubiquitylated and targeted to the proteasome for degradation. The generated peptides are then either translocated back into the phagosome by TAP and loaded onto MHC-I (1) or fed into the classical TAP-dependent MHC-I antigen presentation pathway in the ER (2). ERGIC-derived membranes that fuse with phagosomes are the likely source of the phagosomal retrotranslocon, TAP, and perhaps newly synthesized MHC-I. Right, the TAP- and proteasome-independent vacuolar pathway. In this scenario, peptides are generated from antigens on phagocytosed particles within phagosomes by proteolysis mediated by cathepsins. These peptides are then loaded onto itinerant MHC-I molecules within the phagosome.